Affiliation:
1. Department of Respiratory Therapy, Batterjee Medical College
2. Dammam Medical Complex, Eastern Health Cluster
3. Department of Rehabilitation Science, College of Applied Medical Sciences, King Saud University
4. Department of Medical Laboratory, King Fahad Armed Hospital
5. Department of Respiratory Therapy, College of Health Science, University of Doha for Science and Technology
Abstract
Abstract
Background: Smoking is a leading cause of heart and lung diseases worldwide. Though there is a decline in tobacco smoking the use of e-cigarettes is growing in popularity.
Objective: To assess the long-term effects of smoking, vaping, and dual use on cardiopulmonary function capacity and quality of life.
Methods: The study participants were classified into five groups: Control, Individuals who use cigarettes only, Individuals who only use e-cigarettes, Individuals who previously smoked and currently use only e-cigarettes and Individuals who use both cigarettes and e-cigarettes. Participants performed PFT, 6MWT and completed HRQoL questionnaire.
Results: A total of 175(85.7% male) participants with an average age of mean(±SD)27.38(±5.75) enrolled in the study. PFT results showed significant difference in FEV1(L/Sec) [F (4,170) = 7.73, p≤ 0.001] η²=0.15; FEV1(%predicted) [F (4,170) =24.63, p≤0.001] η²=0.36; and FEV1/FVC (%) [F (4,170) =16.85, p≤0.001] η² = 0.28 values across the five groups. On further analysis, FEV1 and FEV1 (%predicted) significantly decreased in all user groups. Similarly, in FEV1/FVC (%) significant difference was observed with user groups except those who only use e-cigarettes. 6MWT showed a significant difference in walking distance [F (4,170) = 19.93, p≤0.001] η² =0.31. HRQoL reported a significant difference in physical function [H (4) =20.55, p≤0.001], emotional well-being [H (4) =19.21, p=0.001], and social function [H (4) =29.63, p≤0.001] domains. Individuals who use both cigarettes and e-cigarettes reported a significant decline in lung function [(FEV1 2.96±0.41, FEV1 (% predicted) 72.6±6.07 and FEV1/FVC (%) 73.65±11], 6MWT walking distance(m) (mean ±SD) 416.26±53.49.
Conclusion: We observed a significant long-term impairment in lung function, cardiopulmonary capacity, and quality of life among individuals who use cigarettes and e-cigarettes compared to those who never smoked or vaped. Also, individuals who use both cigarettes and e-cigarettes showed the worst health outcomes.
Publisher
Research Square Platform LLC